Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-12-09 02:28:48 UTC |
---|
Updated at | 2021-08-19 23:59:37 UTC |
---|
NP-MRD ID | NP0005145 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Mycophenolic acid |
---|
Provided By | NPAtlas |
---|
Description | Mycophenolic acid, also known as mycophenolate or acide mycophenolique, belongs to the class of organic compounds known as phthalides. Phthalides are compounds containing a 3-hydrocarbylidene-2-benzofuran-1(3H)-one moiety,. Mycophenolic acid is a drug which is used for the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids. In humans, mycophenolic acid is involved in the mycophenolic acid metabolism pathway. Mycophenolic acid is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Mycophenolic acid is found in Aspergillus sp., Parastagonospora nodorum, Penicillium echinulatum, Penicillium griseofulvum, Penicillium parvum and Penicillium roqueforti. Mycophenolic acid was first documented in 1952 (PMID: 14934668). Based on a literature review a small amount of articles have been published on Mycophenolic acid (PMID: 11272311) (PMID: 15470161) (PMID: 16629948) (PMID: 16640327). |
---|
Structure | [H]OC(=O)C([H])([H])C([H])([H])C(=C(/[H])C([H])([H])C1=C(O[H])C2=C(C(=C1OC([H])([H])[H])C([H])([H])[H])C([H])([H])OC2=O)\C([H])([H])[H] InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+ |
---|
Synonyms | Value | Source |
---|
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid | ChEBI | Acide mycophenolique | ChEBI | Acido micofenolico | ChEBI | Acidum mycophenolicum | ChEBI | Micofenolico acido | ChEBI | Mycophenolate | ChEBI | Mycophenolsaeure | ChEBI | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate | Generator | Mycophenoic acid | HMDB | Acid, mycophenolic | HMDB | Cellcept | HMDB | Mofetil hydrochloride, mycophenolate | HMDB | Mofetil, mycophenolate | HMDB | Mycophenolate sodium | HMDB | Mycophenolate, sodium | HMDB | Sodium mycophenolate | HMDB | Mycophenolate mofetil | HMDB | Mycophenolate mofetil hydrochloride | HMDB | Mycophenolic acid morpholinoethyl ester | HMDB | Myfortic | HMDB |
|
---|
Chemical Formula | C17H20O6 |
---|
Average Mass | 320.3371 Da |
---|
Monoisotopic Mass | 320.12599 Da |
---|
IUPAC Name | (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid |
---|
Traditional Name | mycophenolic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(O)=O |
---|
InChI Identifier | InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+ |
---|
InChI Key | HPNSFSBZBAHARI-RUDMXATFSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phthalides. Phthalides are compounds containing a 3-hydrocarbylidene-2-benzofuran-1(3H)-one moiety,. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Isocoumarans |
---|
Sub Class | Isobenzofuranones |
---|
Direct Parent | Phthalides |
---|
Alternative Parents | Not Available |
---|
Substituents | Not Available |
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - BIRKINSHAW JH, RAISTRICK H, ROSS DJ: Studies in the biochemistry of micro-organisms. 86. The molecular constitution of mycophenolic acid, a metabolic product of Penicillium Brevi-compactum Dierckx. Part III. Further observations on the structural formula for mycophenolic acid. Biochem J. 1952 Mar;50(5):630-4. doi: 10.1042/bj0500630. [PubMed:14934668 ]
- Hosotsubo H, Takahara S, Kokado Y, Permpongkosol S, Wang JD, Tanaka T, Matsumiya K, Kitamura M, Okuyama A, Sugimoto H: Rapid and simple determination of mycophenolic acid in human plasma by ion-pair RP-LC with fluorescence detection. J Pharm Biomed Anal. 2001 Feb;24(4):555-60. doi: 10.1016/s0731-7085(00)00442-8. [PubMed:11272311 ]
- Picard N, Ratanasavanh D, Premaud A, Le Meur Y, Marquet P: Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos. 2005 Jan;33(1):139-46. doi: 10.1124/dmd.104.001651. Epub 2004 Oct 6. [PubMed:15470161 ]
- Dzidic A, Prgomet C, Mohr A, Meyer K, Bauer J, Meyer HH, Pfaffl MW: Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep. J Vet Med A Physiol Pathol Clin Med. 2006 May;53(4):163-9. doi: 10.1111/j.1439-0442.2006.00809.x. [PubMed:16629948 ]
- Chong CR, Qian DZ, Pan F, Wei Y, Pili R, Sullivan DJ Jr, Liu JO: Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J Med Chem. 2006 May 4;49(9):2677-80. doi: 10.1021/jm051225t. [PubMed:16640327 ]
|
---|